Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Long QT genes mostly short on evidence

Feb. 3, 2020

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Jan. 28, 2020

Retinoic X receptor as therapeutic target for poststroke recovery

Jan. 28, 2020

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Jan. 27, 2020

Fat or fiber, cFAP activation is problematic for heart

Jan. 27, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

HDAC blockade seen to restore cardiopulmonary function in felines

Jan. 16, 2020

Cynata receives approval for its U.K. phase II study in critical limb ischemia

Jan. 15, 2020

Targeting SMPD1 ameliorates leptin resistance-derived endothelial dysfunction in rats

Jan. 15, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.